References
- Moffarah AS, Al Mohajer M, Hurwitz BL, Armstrong DG. Skin and soft tissue infections. Microbiol Spectr. 2016; 4. doi: 10.1128/microbiolspec.DMIH2-0014-2015
- McEwen SA, Collignon PJ. Antimicrobial resistance: a one health perspective. Microbiol Spectr. 2018; 6. doi: 10.1128/microbiolspec.ARBA-0009-2017
- Ohnishi T, Watanabe S, Matsumoto T, Yotsuyanagi H, Sato J, Kobayashi I, et al. The second nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from skin and soft-tissue infections in dermatology departments in Japan. J Infect Chemother. 2023; 29:143–9. doi: 10.1016/j.jiac.2022.10.005
- Burnham JP, Kollef MH. Treatment of severe skin and soft tissue infections: a review. Curr Opin Infect Dis. 2018; 31:113–9. doi: 10.1097/QCO.0000000000000431
- Rath E, Skrede S, Oppegaard O, Bruun T. Non-purulent skin and soft tissue infections: predictive power of a severity score and the appropriateness of treatment in a prospective cohort. Infect Dis (Lond). 2020; 52:361–71. doi: 10.1080/23744235.2020.1726447
- Stieferman AE, Mazi P, Burnham JP. Severe skin and soft-tissue infections. Semin Respir Crit Care Med. 2022; 43:3–9. doi: 10.1055/s-0041-1740974
- Walsh TL, Chan L, Konopka CI, Burkitt MJ, Moffa MA, Bremmer DN, et al. Appropriateness of antibiotic management of uncomplicated skin and soft tissue infections in hospitalized adult patients. BMC Infect Dis. 2016; 16:721. doi: 10.1186/s12879-016-2067-0
- Khan RMA, Dodani SK, Nadeem A, Jamil S, Zafar MN. Bacterial isolates and their antimicrobial susceptibility profile of superficial and deep-seated skin and soft tissue infections. Asian Biomed (Res Rev News). 2023; 17:55–63.
- Antunes P, Novais C, Peixe L. Food-to-humans bacterial transmission. Microbiol Spectr. 2020; 8. doi: 10.1128/microbiolspec.MTBP-0019-2016